| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697539 | Cancer Treatment and Research Communications | 2017 | 6 Pages |
Abstract
Alternate-day administration of S-1 demonstrated less toxicity without attenuating therapeutic effectiveness among patients with NSCLC. These are promising data to proceed on to validation studies of alternate-day administration of S-1.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Aya Suzuki, Makoto Maemondo, Shunichi Sugawara, Taku Nakagawa, Kageaki Taima, Akira Inoue, Kazuhiko Matsuno, Kazuhiro Usui, Takashi Yokoi, Mariko Kanbe, Toshihiro Nukiwa,